Literature DB >> 8432985

Cytokine production in BALB/c mice immunized with radiation attenuated third stage larvae of the filarial nematode, Brugia pahangi.

A J Bancroft1, R K Grencis, K J Else, E Devaney.   

Abstract

BALB/c mice immunized with radiation attenuated third stage larvae of the filarial nematode Brugia pahangi are strongly immune to challenge infection. Investigation of the profile of cytokines secreted by spleen cells from immune mice stimulated in vitro with either parasite Ag or with Con A revealed high levels of IL-5 and IL-9 and moderate levels of IL-4. In contrast, secretion of IFN-gamma by spleen cells from immune animals was negligible. Spleen cells from control mice secreted low levels of all cytokines assayed. Levels of parasite-specific IgE were significantly elevated in immune animals and a peripheral blood eosinophilia was observed, which exhibited a biphasic distribution. Our results are consistent with the preferential expansion of Th2 cells in immune animals and provide the basis for dissecting the means by which radiation attenuated larvae of filarial nematodes stimulate immunity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432985

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Mice genetically deficient in immunoglobulin E are more permissive hosts than wild-type mice to a primary, but not secondary, infection with the filarial nematode Brugia malayi.

Authors:  L A Spencer; P Porte; C Zetoff; T V Rajan
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 2.  IL-9 and Th9 in parasite immunity.

Authors:  P Licona-Limón; A Arias-Rojas; E Olguín-Martínez
Journal:  Semin Immunopathol       Date:  2016-11-29       Impact factor: 9.623

3.  Infection outcome and cytokine gene expression in Brugia pahangi- infected gerbils (Meriones unguiculatus) sensitized with Brucella abortus.

Authors:  Sharon R Chirgwin; Philip H Elzer; Sharon U Coleman; Jena M Nowling; Sue D Hagius; Matthew D Edmonds; Thomas R Klei
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

4.  Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.

Authors:  P S Turaga; T J Tierney; K E Bennett; M C McCarthy; S C Simonek; P A Enyong; D W Moukatte; S Lustigman
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  Anti-interleukin-4 modulation of the Th2 polarized response to the parasitic nematode Brugia pahangi.

Authors:  J Osborne; S J Hunter; E Devaney
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

6.  Serum cytokine levels in human ascariasis and toxocariasis.

Authors:  Nancy Malla; Bashir Ahmad Fomda; Manzoor Ahmad Thokar
Journal:  Parasitol Res       Date:  2005-12-28       Impact factor: 2.289

7.  Experimental infection of a nonhuman primate with Loa loa induces transient strong immune activation followed by peripheral unresponsiveness of helper T cells.

Authors:  E Leroy; S Baize; G Wahl; T G Egwang; A J Georges
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

8.  Onchocerca volvulus larval antigen, OvB20, induces partial protection in a rodent model of onchocerciasis.

Authors:  M J Taylor; N Abdel-Wahab; Y Wu; R E Jenkins; A E Bianco
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi.

Authors:  S K Verma; I Bansal; S Vedi; J K Saxena; V M Katoch; S M Bhattacharya
Journal:  Parasitol Res       Date:  2007-12-07       Impact factor: 2.289

10.  T cells are required for host protection against Brugia malayi but need not produce or respond to interleukin-4.

Authors:  L Spencer; L Shultz; T V Rajan
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.